LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

LifeMD, Inc.NASDAQ: LFMD

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue dips below year-ago levels

Q1 FY2026 cost of revenue of $7.6M fell 12.1% year over year, behind the +10.1% change in trailing-twelve-month cost of revenue. Sequentially, it fell 10.8% from the prior quarter. Over 3 fiscal years it compounded at +28.2% a year.

Context

  • Cost of revenue amounted to 20.2% of revenue in FY2025, up 8.9 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -12.1% toward the trailing-twelve-month pace of +10.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$7.6M-10.8% QoQ
Last fiscal yearDec 2025
$39.29M+63.3% YoY
LTMMar 2026
$30.96M+10.1% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-12.1%——
1 year+63.3%——
3-year CAGR+28.2%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
39.29M USD
Year-over-year change
+63.3%
4-year CAGR
+21.6%

Cost of Revenue vs competitors

How LFMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +10.1% is the 3rd highest of 10, against a peer median of +1.4%.
  • Cost of revenue amounts to 14.1% of revenue for LFMD, versus a peer median of 47.9%.
LFMD Competitors
Cost of Revenue for LFMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HITIHigh Tide Inc.LTM Apr 2026CA$553.94M CAD+35.7%+19.8%82.5%
TBRGTruBridge, Inc.LTM Mar 2026$168.68M USD+1.4%-0.7%48.8%
CERSCerus CorporationLTM Mar 2026$101.8M USD+25.0%+8.5%45.7%
LFMDLifeMD, Inc.LTM Mar 2026$30.96M USD+10.1%+28.2%14.1%
MASS908 Devices Inc.LTM Mar 2026$29.48M USD+5.6%+12.2%51.0%
TKNOAlpha Teknova, Inc.LTM Mar 2026$27.87M USD-7.8%+4.2%66.7%
SENSSenseonics Holdings, Inc.LTM Mar 2026$19.51M USD-11.2%+12.6%47.9%
SGHTSight Sciences, Inc.LTM Mar 2026$11M USD-1.8%-4.7%13.8%
SMTISanara MedTech Inc.LTM Mar 2026$9.48M USD+7.9%+17.0%8.8%
CVRXCVRx, Inc.LTM Mar 2026$8.55M USD-0.9%+18.5%14.5%
Peer median (excluding LFMD) —+1.4%+12.2%47.9%

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue92.88M119.03M152.55M212.45M194.06M
Cost of Revenue18M18.67M18.9M24.07M39.29M
Gross Profit74.88M100.37M133.65M188.39M154.76M
Gross Margin80.6%84.3%87.6%88.7%79.8%
Research & Development948.16K2.97M6.06M9.51M7.35M
Selling, General & Admin122.08M125.33M128.15M175.68M144.01M
Operating Expenses129.18M143.81M148.14M204.53M162.43M
Depreciation & Amortization355.87K1.09M6.6M9.49M7.31M
EBITDA(57.94M)(38.6M)(8.21M)(6.65M)(1.52M)
EBITDA Margin-62.4%-32.4%-5.4%-3.1%-0.8%
Operating Income(54.3M)(43.45M)(14.49M)(16.14M)(7.67M)
Operating Margin-58.5%-36.5%-9.5%-7.6%-4.0%
Interest Income00000
Interest Expense3.02M1.28M2.6M2.18M1.36M
Other Income / Expenses(7.02M)(1.21M)(2.92M)(2.18M)(2.52M)
Income Before Tax(61.32M)(44.66M)(17.41M)(18.33M)(10.19M)
Pre-Tax Margin-66.0%-37.5%-11.4%-8.6%-5.2%
Income Tax Expense7.7K360.7K428K402K45.72K
Net Income(60.9M)(45.54M)(20.6M)(18.88M)(7.11M)
Net Margin-65.6%-38.3%-13.5%-8.9%-3.7%
EPS (Basic)(2.27)(1.57)(0.70)(0.53)(0.23)
EPS (Diluted)(2.27)(1.57)(0.70)(0.53)(0.23)
Weighted Avg Shares27.01M30.98M33.91M41.2M45.13M
Weighted Avg Shares (Diluted)27.01M30.98M33.91M41.2M45.13M

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.